×
About 6,398 results

ALLMedicine™ Vitiligo Center

Research & Reviews  2,039 results

Evaluation of serum and tissue levels of cold-inducible RNA-binding protein in non-segm...
https://doi.org/10.1007/s00403-023-02586-6
Archives of Dermatological Research; Moftah NH, Alnos H et. al.

Mar 16th, 2023 - Damage-associated molecular patterns (DAMPs) play a role in the pathogenesis of vitiligo. It has been established that the cold-inducible RNA-binding protein (CIRP), a member of the family of cold-shock proteins that respond to stress, is a DAMP m...

The possible role of Wnt/β-catenin signaling in vitiligo treatment.
https://doi.org/10.1111/jdv.19022
Journal of the European Academy of Dermatology and Venere... Lin X, Meng X et. al.

Mar 14th, 2023 - Vitiligo is a common chronic skin disease which has an adverse impact on the patients' life. Its pathogenesis is complex, involving autoimmunity and oxidative stress (OS). Autoimmunity leads to the loss of epidermal melanocytes and the formation o...

Carotenemia
http://emedicine.medscape.com/article/1104368-overview

Mar 14th, 2023 - Practice Essentials Carotenemia is a clinical condition characterized by yellow pigmentation of the skin (xanthoderma) and increased beta-carotene levels in the blood. In most cases, the condition follows prolonged and excessive consumption of car...

Carotenemia
https://emedicine.medscape.com/article/1104368-print

Mar 14th, 2023 - Practice Essentials Carotenemia is a clinical condition characterized by yellow pigmentation of the skin (xanthoderma) and increased beta-carotene levels in the blood. In most cases, the condition follows prolonged and excessive consumption of car...

Carotenemia
https://emedicine.medscape.com/article/1104368-overview

Mar 14th, 2023 - Practice Essentials Carotenemia is a clinical condition characterized by yellow pigmentation of the skin (xanthoderma) and increased beta-carotene levels in the blood. In most cases, the condition follows prolonged and excessive consumption of car...

see more →

Guidelines  1 results

Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
https://doi.org/10.1111/j.1365-2133.2012.11197.x
The British Journal of Dermatology; Taieb A, Alomar A et. al.

Aug 7th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  212 results

A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions
https://clinicaltrials.gov/ct2/show/NCT05084417

Mar 3rd, 2023 - The study is a multi-center, longitudinal, observational study to describe longitudinal trajectories of Clinician-Reported Outcomes (ClinROs) and Patient-Reported Outcomes (PROs) in patients with select dermatological conditions. This study will c...

A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo
https://clinicaltrials.gov/ct2/show/NCT05750823

Mar 2nd, 2023 - An open-label study in which participants with non-segmental vitiligo with genital involvement will apply ruxolitinib 1.5% cream twice a day (BID) to all depigmented areas (up to 10% BSA) for up to 48 weeks. Participants should continue to treat d...

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Vitiligo (Active and Stable)
https://clinicaltrials.gov/ct2/show/NCT05583526

Feb 24th, 2023 - Study B7981040 is a Phase 3 randomized, double-blind, 52-week placebo-controlled, multi center study investigating the efficacy, safety, and tolerability of ritlecitinib in adult and adolescent participants with non segmental vitiligo (both active...

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
https://clinicaltrials.gov/ct2/show/NCT04927975

Feb 14th, 2023 - Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate how safe and effective upadacitinib is in participants with non-segmental vitiligo. Adve...

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo
https://clinicaltrials.gov/ct2/show/NCT04872257

Feb 14th, 2023 - A randomized clinical trial, triple-blind, placebo-controlled treating patients with diagnosed vitiligo. The intervention group will be treated with oral vitamin D 5,000 IU per day and NB-UVB phototherapy. The control group will be treated with pl...

see more →

News  284 results

ICI-Related Myocarditis Deaths Down With Tailored Non-Corticosteroid Strategy
https://www.medpagetoday.com/cardiology/prevention/103226

Feb 23rd, 2023 - For immune checkpoint inhibitor (ICI)-associated myocarditis, increased vigilance of respiratory muscle failure and initiation of JAK‐STAT pathway inhibition led to a jump in patient survival at a Paris hospital. Based on 40 consecutive cancer pat...

An 11-year-old boy presents with small itchy bumps on the wrists, face, arms, and legs
https://www.mdedge.com/pediatrics/article/261183/dermatology/11-year-old-boy-presents-small-itchy-bumps-wrists-face-arms
Catalina Matiz, MD

Feb 13th, 2023 - The patient was diagnosed with lichen nitidus, given the characteristic clinical presentation. Lichen nitidus is a rare chronic inflammatory condition of the skin that most commonly presents in children and young adults and does not seem to be res.

Vitiligo
https://www.mdedge.com/familymedicine/article/260801/diversity-medicine/vitiligo
MDedge Family Medicine; Uzoamaka Okoro, MD, MSc, Candrice R. Heath, MD et. al.

Jan 25th, 2023 - THE COMPARISON A Vitiligo in a young Hispanic female, which spared the area under a ring. The patient has spotty return of pigment on the hand after narrowband ultraviolet B (UVB) treatment.

Pigmentary disorder experts welcome research explosion
https://www.mdedge.com/dermatology/article/260792/pigmentation-disorders/pigmentary-disorder-experts-welcome-research
Tom Collins

Jan 25th, 2023 - ORLANDO – Research on pigmentary disorders has entered an overdue era of increased attention, resulting in more treatment options and the promise of improved quality of life for patients, a panel of experts said in a session on this topic at the O.

Microneedling With Bimatoprost to Treat Hypopigmented Skin Caused by Burn Scars
https://www.mdedge.com/dermatology/article/260747/pigmentation-disorders/microneedling-bimatoprost-treat-hypopigmented-skin
Nghi Nguyen, BA, Jaqueline Helms, BA et. al.

Jan 24th, 2023 - To the Editor: Microneedling is a percutaneous collagen induction therapy frequently used in cosmetic dermatology to promote skin rejuvenation and hair growth and to treat scars by taking advantage of the body’s natural wound-healing cascade. 1 The.

see more →

Patient Education  15 results see all →